34.55USD+6.01%Mkt Cap: 137.33M USDP/E: —Last update: 2026-06-01
vTv Therapeutics Inc., a late-stage biopharmaceutical company, focuses on developing oral small molecule drug candidates intended to treat people living with diabetes and other chronic diseases. Its lead drug candidate i…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap137.33M USD
Enterprise Value315.76M USD
Revenue (TTM)36.84M USD
Gross Profit12.83M USD
Net Income (TTM)-26.97M USD
Revenue/Share3.729 USD
Last Price34.55 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees26
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-8.57
PEG—
EV/EBITDA-104.08
EV/Revenue8.57
P/S3.57
P/B6.42
EPS (TTM)-0.78
EPS (Forward)-3.89
52W Range
14.0068% of range44.00
52W High44.00 USD
52W Low14.00 USD
Profitability
Gross Margin34.83%
Oper. Margin63.15%
EBITDA Margin-8.24%
Profit Margin6.11%
ROE-41.86%
ROA-30.00%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-25.25M USD
CapEx (TTM)—
FCF Margin14.33%
FCF Yield3.84%
Net Debt-98.09M USD
Net Debt/EBITDA32.33
Balance Sheet
Debt/Equity0.00
Current Ratio14.36
Quick Ratio14.26
Book Value/Sh5.193 USD
Cash/Share7.904 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:40
Split DateNov 21, 2023
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)53.00 USD
Target Range44.00 USD – 67.00 USD
# Analysts6
Ownership
Shares Out.3.94M
Float2.40M
Insiders38.98%
Institutions38.35%
Short Interest
Short Ratio2.6d
Short % Float6.06%
Short % Out.3.67%
Shares Short144.57K
Short (prev mo.)112.74K
Technical
SMA 5035.51 (-2.7%)
SMA 20030.32 (+13.9%)
Beta0.26
S&P 52W Chg27.70%
Avg Vol (30d)53.81K
Avg Vol (10d)45.17K
Technical Indicators
RSI (14)44.2
MACD-0.2322
MACD Signal-0.2309
MACD Hist.-0.0013
BB Upper38.01 USD
BB Middle33.50 USD
BB Lower28.99 USD
BB Width26.91%
ATR (14)2.487 USD
Vol Ratio (20d)0.36x